Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2026-02-23 @ 11:18 AM
Study NCT ID:
NCT02601950
Status:
COMPLETED
Last Update Posted:
2025-06-22
First Post:
2015-10-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma
Sponsor:
Epizyme, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Malignant Rhabdoid Tumors (MRT) | View |
| None | Rhabdoid Tumors of the Kidney (RTK) | View |
| None | Atypical Teratoid Rhabdoid Tumors (ATRT) | View |
| None | Selected Tumors With Rhabdoid Features | View |
| None | Synovial Sarcoma | View |
| None | INI1-negative Tumors | View |
| None | Malignant Rhabdoid Tumor of Ovary | View |
| None | Renal Medullary Carcinoma | View |
| None | Epithelioid Sarcoma | View |
| None | Poorly Differentiated Chordoma (or Other Chordoma With Sponsor Approval) | View |
| None | Any Solid Tumor With an EZH2 GOF Mutation | View |
Keywords: